LobbyingLymphedema Advocacy Group lobbying by quarter
Lymphedema Advocacy Group's latest lobbying report covers Q2 2024, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid.
Lymphedema Advocacy Group
- Latest quarter
- No record
- Q2 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q2 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $0 | 1 |
| Q1 2023 | $20K | 1 |
| Q2 2023 | $20K | 1 |
| Q3 2023 | $20K | 1 |
| Q4 2023 | $20K | 1 |
| Q1 2024 | $0 | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
Policy issues the reports name
- Medicare and Medicaid5 reports
A report that names several issues counts once for each.
Who was lobbied
- Centers For Medicare and Medicaid Services (CMS)5 reports
- HOUSE OF REPRESENTATIVES5 reports
- SENATE5 reports
Firms it paid
| Firm | ||
|---|---|---|
| Prime Policy Group | $80K | 7 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 24/07/19for Q2 2024 | Prime Policy Group | Under $5,000 |
| 24/04/17for Q1 2024 | Prime Policy Group | Under $5,000 |
| 24/01/18for Q4 2023 | Prime Policy Group | $20K |
| 23/10/19for Q3 2023 | Prime Policy Group | $20K |
| 23/07/18for Q2 2023 | Prime Policy Group | $20K |
| 23/04/19for Q1 2023 | Prime Policy Group | $20K |
| 23/01/18for Q4 2022 | Prime Policy Group | Under $5,000 |